In an otherwise healthy boy with epilepsy who is taking valproic acid, should we test his folate levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should We Test Folate Levels in a Boy with Epilepsy on Valproic Acid?

No, routine folate testing is not necessary in an otherwise healthy boy with epilepsy taking valproic acid, as isolated clinical folate deficiency is extremely rare in Western countries and current evidence does not support routine monitoring in this population. 1

Evidence-Based Rationale

When Folate Testing is Indicated

According to the 2024 ESPEN guidelines, folate testing should be performed in specific clinical scenarios 2:

  • Patients with macrocytic anemia - measure at first assessment and repeat within 3 months after supplementation
  • Patients at risk of malnutrition - same monitoring schedule as above
  • Diseases known to increase folate needs - measure every 3 months until stabilization, then annually

Why Not in This Case?

Your patient does not meet these criteria. The guidelines explicitly state that "cases of isolated clinical folate deficiency are extremely rare" in Western countries 1, 2. The boy is described as "otherwise healthy," which means:

  • No macrocytic anemia
  • No malnutrition
  • No specific disease state increasing folate requirements (chronic kidney disease, hemodialysis, etc.)

The Valproic Acid Consideration

While the ESPEN guidelines note that folic acid "interacts with epilepsy medication" 1, 2, this refers primarily to:

  1. Masking B12 deficiency - a concern when supplementing, not a reason to test
  2. Teratogenicity concerns - relevant for women of childbearing age, not boys

The research evidence shows conflicting results regarding valproic acid's effect on folate:

  • One Nigerian study found lower folate levels in children on long-term antiepileptic drugs 3
  • However, a Turkish study found no significant difference in folate levels between children on valproate versus controls 4
  • A systematic review found that valproate showed "hardly any correlation" with decreased folate levels, unlike carbamazepine 5

What You Should Do Instead

Focus on Supplementation, Not Testing

The more important intervention is folic acid supplementation, not testing. The FDA label for valproic acid specifically warns about neural tube defects in offspring of women taking the medication 6, and recent guidelines emphasize supplementation:

  • The 2024 AAN/AES/SMFM guideline recommends at least 0.4 mg daily of folic acid for any person of childbearing potential on ASMs 7
  • For boys, while not at risk for neural tube defects, the general principle of ensuring adequate folate status applies

Monitor for Clinical Signs Instead

Rather than routine testing, watch for:

  • Hematologic changes: macrocytic anemia, pancytopenia
  • Mucosal symptoms: glossitis, angular stomatitis, oral ulcers
  • Neuropsychiatric symptoms: depression, irritability, cognitive impairment 1, 2

When to Actually Test

Consider folate testing if:

  1. Complete blood count shows macrocytosis - then test both folate AND B12 simultaneously 1
  2. Signs of malnutrition develop
  3. Unexplained neuropsychiatric symptoms emerge
  4. Concurrent conditions develop that increase folate needs

Important Caveats

The B12 Connection

If you do test folate for any reason, always measure B12 simultaneously 1. Folate supplementation can mask B12 deficiency while allowing neurological damage to progress - a critical pitfall to avoid 1.

Homocysteine Consideration

Some research suggests valproic acid may increase homocysteine levels in children, particularly with longer duration of therapy 8, 9. However, this is not currently part of standard monitoring recommendations and requires further study.

Duration of Therapy

The evidence on whether duration of valproic acid therapy affects folate status is mixed. One study found lower folate after >6 months of therapy 3, while another found no effect 4. This inconsistency further argues against routine monitoring.

Bottom Line

In an otherwise healthy boy on valproic acid, clinical vigilance trumps routine laboratory monitoring for folate. Save testing for when clinical indicators emerge, and consider prophylactic supplementation with standard multivitamin doses containing folic acid as a more practical approach.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.